Modulation of the cell membrane lipid milieu by peroxisomal β-oxidation induces Rho1 signaling to trigger inflammatory responses.

Pex1 Pex2 RhoI/A Rhogap190 autoimmune disorders cytokine secretion cytoskeleton remodeling immunometabolism peroxisomes phospholipids

Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
01 03 2022
Historique:
received: 22 03 2021
revised: 21 12 2021
accepted: 01 02 2022
entrez: 2 3 2022
pubmed: 3 3 2022
medline: 12 4 2022
Statut: ppublish

Résumé

Phagocytosis, signal transduction, and inflammatory responses require changes in lipid metabolism. Peroxisomes have key roles in fatty acid homeostasis and in regulating immune function. We find that Drosophila macrophages lacking peroxisomes have perturbed lipid profiles, which reduce host survival after infection. Using lipidomic, transcriptomic, and genetic screens, we determine that peroxisomes contribute to the cell membrane glycerophospholipid composition necessary to induce Rho1-dependent signals, which drive cytoskeletal remodeling during macrophage activation. Loss of peroxisome function increases membrane phosphatidic acid (PA) and recruits RhoGAPp190 during infection, inhibiting Rho1-mediated responses. Peroxisome-glycerophospholipid-Rho1 signaling also controls cytoskeleton remodeling in mouse immune cells. While high levels of PA in cells without peroxisomes inhibit inflammatory phenotypes, large numbers of peroxisomes and low amounts of cell membrane PA are features of immune cells from patients with inflammatory Kawasaki disease and juvenile idiopathic arthritis. Our findings reveal potential metabolic markers and therapeutic targets for immune diseases and metabolic disorders.

Identifiants

pubmed: 35235794
pii: S2211-1247(22)00160-7
doi: 10.1016/j.celrep.2022.110433
pii:
doi:

Substances chimiques

Glycerophospholipids 0
Membrane Lipids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

110433

Subventions

Organisme : CIHR
Pays : Canada

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests All authors declare no competing interests.

Auteurs

Anu S Nath (AS)

Dalhousie University, Department of Microbiology and Immunology, Halifax, NS B3K 6R8, Canada.

Brendon D Parsons (BD)

Dalhousie University, Department of Microbiology and Immunology, Halifax, NS B3K 6R8, Canada.

Stephanie Makdissi (S)

Dalhousie University, Department of Microbiology and Immunology, Halifax, NS B3K 6R8, Canada.

Rebecca L Chilvers (RL)

Dalhousie University, Department of Microbiology and Immunology, Halifax, NS B3K 6R8, Canada.

Yizhu Mu (Y)

Dalhousie University, Department of Microbiology and Immunology, Halifax, NS B3K 6R8, Canada.

Ceileigh M Weaver (CM)

Dalhousie University, Department of Microbiology and Immunology, Halifax, NS B3K 6R8, Canada.

Irene Euodia (I)

Dalhousie University, Department of Microbiology and Immunology, Halifax, NS B3K 6R8, Canada.

Katherine A Fitze (KA)

Dalhousie University, Department of Microbiology and Immunology, Halifax, NS B3K 6R8, Canada.

Juyang Long (J)

Dalhousie University, Department of Microbiology and Immunology, Halifax, NS B3K 6R8, Canada.

Michal Scur (M)

Dalhousie University, Department of Microbiology and Immunology, Halifax, NS B3K 6R8, Canada.

Duncan P Mackenzie (DP)

Dalhousie University, Department of Microbiology and Immunology, Halifax, NS B3K 6R8, Canada.

Andrew P Makrigiannis (AP)

Dalhousie University, Department of Microbiology and Immunology, Halifax, NS B3K 6R8, Canada.

Nicolas Pichaud (N)

Université de Moncton, Department of Chemistry and Biochemistry, Moncton, NB E1A 3E9, Canada; New Brunswick Centre for Precision Medicine (NBCPM), Moncton, NB E1A 3E9, Canada.

Luc H Boudreau (LH)

Université de Moncton, Department of Chemistry and Biochemistry, Moncton, NB E1A 3E9, Canada; New Brunswick Centre for Precision Medicine (NBCPM), Moncton, NB E1A 3E9, Canada.

Andrew J Simmonds (AJ)

University of Alberta, Department of Cell Biology, Edmonton, AB T6G 2H7, Canada.

Christine A Webber (CA)

University of Alberta, Department of Cell Biology, Edmonton, AB T6G 2H7, Canada.

Beata Derfalvi (B)

Dalhousie University, Department of Pediatrics, Halifax, NS B3K 6R8, Canada.

Yannick Hammon (Y)

INSERM au Centre d'Immunologie de Marseille Luminy, Marseille 13288, France.

Richard A Rachubinski (RA)

University of Alberta, Department of Cell Biology, Edmonton, AB T6G 2H7, Canada.

Francesca Di Cara (F)

Dalhousie University, Department of Microbiology and Immunology, Halifax, NS B3K 6R8, Canada; Dalhousie University, Department of Pediatrics, Halifax, NS B3K 6R8, Canada. Electronic address: dicara@dal.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH